Back to Home
Read full article at source




Oxford begins first human trial of new Lassa Fever vaccine
Premium Times•about 1 month ago•centre•Credibility: 85/100
Thirty-one healthy adults aged 18 to 55 will take part in the trial in Oxford, while a second phase-1 trial is expected to begin in Ghana early 2026. The post Oxford begins first human trial of new Lassa Fever vaccine appeared first on Premium Times Nigeria.
Community Reactions
AI-Powered Insights
Related Stories

JUST IN: Kano govt suspends doctors who left scissors in patient’s stomach
Daily Trustabout 4 hours ago

Army Offers Free Medical Services to 1,000 Persons in Sokoto
This Dayabout 5 hours ago

How my wife died after doctors allegedly left scissors in her stomach – Husband
Daily Trustabout 7 hours ago

FCTA lauds health fellows’ roles in healthcare delivery
Daily Trustabout 10 hours ago


Discussion (0)